院内心搏骤停的原位模拟培训
美国每年超过30万例院内心搏骤停,虽近20年生存率有所改善,但结局仍差,且风险标化生存率在医院间差异显著,提示流程改进空间。定期多学科原位心搏骤停模拟被识别为院内心搏骤停结局最佳医院共同特征,但尚无明确建立方法。本文以「How I Do It」形式描述建立稳健可持续原位心搏骤停模拟项目的框架,包括获取赞助与组建多学科团队、设备资源获取与维护、执行逼真模拟、促进结构化复盘与持续质量改进,并提供即用工具,使医院能够实施可持续项目并推动可测量的照护与结局改善。
要点
- 美国每年超过30万例院内心搏骤停,近20年生存率改善但结局仍差,许多初始幸存者出院时遗留严重残疾。
- 美国院内心搏骤停风险标化生存率医院间差异显著,提示流程改进空间;改善照护流程与结局是Joint Commission、American Hospital Association等国家机构的优先事项。
- 定期多学科原位心搏骤停模拟被识别为院内心搏骤停结局最佳医院共同特征,但最佳改善方法尚未明确。
- 本文描述建立稳健可持续原位心搏骤停模拟项目的框架:获取赞助与组建多学科团队、设备资源获取与维护、执行逼真模拟、结构化复盘与持续质量改进。
- 作者提供的框架与即用工具旨在使医院能够实施可持续原位院内心搏骤停模拟项目,并推动可测量的照护与结局改善。
适用人群与场景
- 院内心搏骤停患者:美国每年超过30万例。
- 参与院内心搏骤停照护的多学科团队。
处置流程与药物剂量
- 获取赞助并组建多学科团队。
- 获取与维护设备及资源。
- 执行逼真的原位模拟。
- 促进结构化复盘与持续质量改进。
研究设计与关键结果
- 本文为「How I Do It」类型文章,描述建立稳健且可持续的原位心搏骤停模拟项目的框架,包括获取赞助与组建多学科团队、设备资源获取与维护、执行逼真模拟、结构化复盘与持续质量改进,并提供即用工具。
证据类型、等级与局限
- 证据类型:专家经验(How I Do It)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,定期多学科原位心搏骤停模拟是院内心搏骤停结局最佳医院的共同特征。
- 作者提供的框架与即用工具旨在使医院能够实施可持续的原位院内心搏骤停模拟项目,并推动可测量的照护与结局改善。
指南或共识出处
- Chest「How I Do It」专栏:In Situ Cardiac Arrest Simulation。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Over 300,000 patients experience in-hospital cardiac arrest in the United States each year, resulting in substantial morbidity, mortality, and loss of disability-adjusted life years. Although survival after in-hospital cardiac arrest has improved over the past 2 decades, outcomes remain poor and many initial survivors of in-hospital cardiac arrest are discharged with substantial disability. Across the United States, risk-standardized survival after in-hospital cardiac arrest varies significantly, reflecting potential for process improvement. Improving processes of care and outcomes after in-hospital cardiac arrest is a priority of national organizations such as the Joint Commission, the American Hospital Association, and other professional bodies. Nevertheless, best approaches to improving in-hospital cardiac arrest care have not been well defined. Performance of regular multidisciplinary in situ cardiac arrest simulations has been identified as a trait common to best performing hospitals with respect to in-hospital cardiac arrest outcomes. However, no clear approach to establishing an in situ cardiac arrest program has been established. In this How I Do It installment, we describe the creation of a robust and sustainable in situ cardiac program including securing sponsorship and assembling a multidisciplinary team, acquiring and maintaining equipment and resources, execution of realistic simulations, and facilitating structured debriefings and continuous quality improvement. Our framework and ready-to-use tools will enable hospitals to implement sustainable in situ in-hospital cardiac arrest simulation programs and drive measurable improvements in care and outcomes.
参考来源
- Moskowitz A, Paul A, Ferguson N, et al. In Situ Cardiac Arrest Simulation. Chest. 2025. PMID: 40945713. doi:10.1016/j.chest.2025.09.003
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。